Indeed, there are now several dual GIP/GLP-1 receptor agonists in clinical development, including tirzepatide, which was approved by the FDA and EMA for the treatment of type 2 diabetes in 2022
By respecting the shelf life of your medication, you ensure that every dose you take is working at its full potential to help you reach your goals
While they do use their scale to negotiate significant discounts off a drugs list price, their business models create incentives that can undermine overall cost savings
Women exposed also had a higher frequency of pre-existing diabetes: 34% compared to 1.5%, and 47% compared to 1.6%, for women exposed to liraglutide or semaglutide, respectively (equaling a 22.729.4-fold higher frequency for liraglutide and semaglutide exposure, respectively)
Current Data in Oncology Population GLP-1 RAs and Risk for Thyroid Cancer As previously stated, the packaging of GLP-1 RAs includes a boxed warning for thyroid cancers, but what can the studies in human participants tell us about this risk ( Table 3 )
